107 related articles for article (PubMed ID: 17479870)
1. [Pharmacological mechanisms of Doxorubicin activity (DOX) - current state of knowledge].
Łubgan D; Marczak A; Walczak M; Distel L; Jóźwiak Z
Przegl Lek; 2006; 63(9):782-8. PubMed ID: 17479870
[TBL] [Abstract][Full Text] [Related]
2. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis.
Gilleron M; Marechal X; Montaigne D; Franczak J; Neviere R; Lancel S
Biochem Biophys Res Commun; 2009 Oct; 388(4):727-31. PubMed ID: 19699179
[TBL] [Abstract][Full Text] [Related]
4. Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts.
Choi HJ; Seon MR; Lim SS; Kim JS; Chun HS; Park JH
Exp Biol Med (Maywood); 2008 Dec; 233(12):1554-60. PubMed ID: 18849542
[TBL] [Abstract][Full Text] [Related]
5. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
Khdair A; Handa H; Mao G; Panyam J
Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
[TBL] [Abstract][Full Text] [Related]
7. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets.
Sardão VA; Oliveira PJ; Holy J; Oliveira CR; Wallace KB
Cell Biol Toxicol; 2009 Jun; 25(3):227-43. PubMed ID: 18386138
[TBL] [Abstract][Full Text] [Related]
8. Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells.
Lin X; Li Q; Wang YJ; Ju YW; Chi ZQ; Wang MW; Liu JG
Biochem J; 2007 Sep; 406(2):215-21. PubMed ID: 17542780
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline drug targeting: cytoplasmic versus nuclear--a fork in the road.
Lothstein L; Israel M; Sweatman TW
Drug Resist Updat; 2001 Jun; 4(3):169-77. PubMed ID: 11768330
[TBL] [Abstract][Full Text] [Related]
10. Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation.
Hovorka O; Subr V; Větvička D; Kovář L; Strohalm J; Strohalm M; Benda A; Hof M; Ulbrich K; Ríhová B
Eur J Pharm Biopharm; 2010 Nov; 76(3):514-24. PubMed ID: 20638475
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis.
Lin H; Hou CC; Cheng CF; Chiu TH; Hsu YH; Sue YM; Chen TH; Hou HH; Chao YC; Cheng TH; Chen CH
Mol Pharmacol; 2007 Nov; 72(5):1238-45. PubMed ID: 17671096
[TBL] [Abstract][Full Text] [Related]
12. Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance.
Veitch ZW; Guo B; Hembruff SL; Bewick AJ; Heibein AD; Eng J; Cull S; Maclean DA; Parissenti AM
Pharmacogenet Genomics; 2009 Jun; 19(6):477-88. PubMed ID: 19440163
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M
Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
[TBL] [Abstract][Full Text] [Related]
14. Adriamycin dose and time effects on cell cycle, cell death, and reactive oxygen species generation in leukaemia cells.
Savatier J; Rharass T; Canal C; Gbankoto A; Vigo J; Salmon JM; Ribou AC
Leuk Res; 2012 Jun; 36(6):791-8. PubMed ID: 22417651
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers.
Sun JB; Duan JH; Dai SL; Ren J; Zhang YD; Tian JS; Li Y
Cancer Lett; 2007 Dec; 258(1):109-17. PubMed ID: 17920762
[TBL] [Abstract][Full Text] [Related]
16. The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis.
Frias MA; Somers S; Gerber-Wicht C; Opie LH; Lecour S; Lang U
Cardiovasc Res; 2008 Oct; 80(1):69-77. PubMed ID: 18567640
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin induces biphasic neurotoxicity to rat cortical neurons.
Lopes MA; Meisel A; Dirnagl U; Carvalho FD; Bastos Mde L
Neurotoxicology; 2008 Mar; 29(2):286-93. PubMed ID: 18258305
[TBL] [Abstract][Full Text] [Related]
18. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
19. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
Shen J; Zhang W; Wu J; Zhu Y
Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591
[TBL] [Abstract][Full Text] [Related]
20. 4-Demethoxy-3'-N-trifluoroacetyldoxorubicin. Synthesis and solid tumor activity.
Horton D; Priebe W; Carter JP; Filppi J; Wolgemuth RL
Drug Des Deliv; 1990 Jun; 6(2):123-9. PubMed ID: 2080980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
